The total return over the past 12 months is +659.18% vs. +16.94% for the S&P 500. So far it's up +499.26% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +659.18% | +36.07% | (7.24%) | N/A | N/A | N/A |
| Total Return CAGR | +659.18% | +36.07% | (7.24%) | N/A | N/A | N/A |
| Revenue CAGR | (4.28%) | +2.77% | +8.74% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | +113.51% | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +89.82% | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
10x Genomics, Inc. (TXG)
| Year | Start price | End price | TXG Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $16.31 | $97.74 | +499.26% | +14.51% | +484.75% |
| 2025 | $14.36 | $16.31 | +13.58% | +17.72% | (4.14%) |
| 2024 | $55.96 | $14.36 | (74.34%) | +24.89% | (99.23%) |
| 2023 | $36.44 | $55.96 | +53.57% | +26.19% | +27.38% |
| 2022 | $148.96 | $36.44 | (75.54%) | (18.17%) | (57.37%) |
| 2021 | $141.60 | $148.96 | +5.20% | +28.74% | (23.54%) |
| 2020 | $76.25 | $141.60 | +85.70% | +18.37% | +67.33% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
